학술논문
A phase 2 study of ibrutinib in combination with bortezomib and dexamethasone in patients with relapsed/refractory multiple myeloma
Document Type
Article
Author
Source
In: European Journal of Haematology . (European Journal of Haematology, 1 May 2020, 104(5):435-442)
Subject
Language
English
ISSN
16000609
09024441
09024441